Table 2.

Pharmacokinetic Parameters

Parameter	Bezafibrate Powder	Electrosprayed Solid Dispersion Formulation V
AUC (h· μg/mL)	17.83 ± 1.63	96.91 ± 15.63*
Cmax (μg/mL)	2.47 ± 0.45	9.25 ± 2.58*
Tmax (h)	1.69 ± 0.31	1.86 ± 0.38

Notes: Each value indicates the mean ± S.D. (n=6). *p < 0.05 (t-test) compared with bezafibrate powder.